Andrea Pallotta

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Multicenter point-prevalence evaluation of the utilization and safety of drug therapies for COVID-19”.

Multicenter point-prevalence evaluation of the utilization and safety of drug therapies for COVID-19

medRxiv(2020)10.1101/2020.06.03.20121558

N/A

0DataRank · unranked

3 citations

Atheer Dairem, William J Moore, Anooj Shah, Michael Postelnick, Melissa E. Badowski +11 more

Multicenter point prevalence evaluation of the utilization and safety of drug therapies for COVID-19 at the onset of the pandemic timeline in the United States

American Journal of Health-System Pharmacy(2021)10.1093/ajhp/zxaa426

N/A

0DataRank · unranked

6 citations

Atheer Dairem, William J Moore, Anooj Shah, Michael Postelnick, Melissa E. Badowski +11 more

Baricitinib versus tocilizumab in critically ill COVID‐19 patients: A retrospective cohort study

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy(2023)10.1002/phar.2867

N/A

0DataRank · unranked

5 citations

Seth R. Bauer, Andrea Pallotta, Abhijit Duggal, Lu Wang, Gretchen L. Sacha +1 more